Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Trump management was awarded $ 766 million to the drug producer Modern Inc tomake a vaccineH5N1 against potential pandemic flu viruses, including bird flu.
The company said on Wednesday that the Department of Health and Human Services will be paid to pay for research and investigation in July 2024 in January vaccination.
The funds were awarded a biomhical advanced research and development application or Barda aimed at medical treatment for potential pandems.
A new vaccine called MRNA-1018 has used the same technologyThe enabled developmentandRounding vaccinesTo fight Covid-19 in a record time.
Health Secretary Robert F. Kennedy Jr. said, associated with MRNA vaccines that are safe and saved the lives of millions of people and are safe in the world.
Cancel, 300 healthy adults, the H5 bird flu virus targeted the vaccine, which targets the vaccine, came as a positive interval.
“When adding uncertainty to the termination of the HHS, we are pleased with the strong immune response and security profile in this intermediate analysis,” the company said.
H5N1 bird flu flu viruses, last year in the United States, poured from the wild bird from the wild bird, and hundreds of animals infected.At least 70 peopleIn the United States, the bird flu infection, mainly moderates were ill. One person died. Scientists are afraid to continue the mutation of the virus that this can allow people to spread more virulence or easier in people who are likely to cause a pandemic.
Moderna received $ 176 million and $ 590 million in January 2024. The January Award would support a late scene clinical trial, including a company spokesman spokesman, including bird flu, which could determine the effectiveness of pandemic viruses.
This story was first displayed Fortune.com
